Crewe Advisors’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11
Closed -$392 1024
2023
Q4
$392 Buy
+11
New +$349 ﹤0.01% 333
2023
Q2
Sell
-140
Closed -$5.5K 1020
2023
Q1
$5.5K Sell
140
-54
-28% -$1.98K ﹤0.01% 623
2022
Q4
$6.18K Sell
194
-121
-38% -$3.65K ﹤0.01% 636
2022
Q3
$9K Buy
315
+48
+18% +$1.64K ﹤0.01% 704
2022
Q2
$10K Buy
+267
New +$10.8K ﹤0.01% 606

Other funds holding XRAY

Crewe Advisors's XRAY Position: Q1 2024 in Review

Crewe Advisors sold out of Dentsply Sirona (XRAY) in Q1 2024, closing a stake of 11 shares — an estimated $392 sold.

Crewe Advisors first reported a position in XRAY in Q2 2022 and held it in 5 quarters. The position peaked at $10K in Q2 2022. 449 funds tracked by Wall St. Rank hold XRAY as of Q1 2024.

  • Crewe Advisors reported no remaining Dentsply Sirona position as of Q1 2024 after selling out during the quarter.
  • Crewe Advisors sold 11 Dentsply Sirona shares in Q1 2024, an estimated $392.
  • Crewe Advisors first reported a position in Dentsply Sirona in Q2 2022 and held it in 5 quarters.
  • Crewe Advisors's Dentsply Sirona position peaked at $10K in Q2 2022.
  • 449 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2024.

Based on Crewe Advisors's 13F filing for Q1 2024, filed 14 May 2024.